(Q53618227)

English

The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16771848%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16771848%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16771848%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

David J Flavell

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16771848%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sarah L Warnes

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16771848%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Christine J Bryson

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16771848%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sarah A Field

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16771848%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Armorel L Noss

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16771848%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sopsamorn U Flavell

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16771848%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

0 references

publication date

12 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16771848%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16771848%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

134

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16771848%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16771848%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

157-170

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16771848%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

A severe combined immunodeficiency mutation in the mouse

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

Complement activation determines the therapeutic activity of rituximab in vivo.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

Rituximab-mediated sensitization of B-non-Hodgkin's lymphoma (NHL) to cytotoxicity induced by paclitaxel, gemcitabine, and vinorelbine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

Characteristics and performance of a bispecific F (ab'gamma)2 antibody for delivering saporin to a CD7+ human acute T-cell leukaemia cell line

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

Homodimers but not monomers of Rituxan (chimeric anti-CD20) induce apoptosis in human B-lymphoma cells and synergize with a chemotherapeutic agent and an immunotoxin.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

Rituximab (anti-CD20) therapy of B-cell lymphomas: direct complement killing is superior to cellular effector mechanisms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

Clustered CD20 induced apoptosis: src-family kinase, the proximal regulator of tyrosine phosphorylation, calcium influx, and caspase 3-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

Requirement for SAPK-JNK signaling in the induction of apoptosis by ribosomal stress in REH lymphoid leukemia cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

Role of caspases in immunotoxin-induced apoptosis of cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

CD20-induced B cell death can bypass mitochondria and caspase activation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

Effectiveness of HB2 (anti-CD7)--saporin immunotoxin in an in vivo model of human T-cell leukaemia developed in severe combined immunodeficient mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

Ribosome-inactivating protein and apoptosis: abrin causes cell death via mitochondrial pathway in Jurkat cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

Ribosome inactivating proteins and apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

Ribosome-inactivating proteins from the seeds of Saponaria officinalis L. (soapwort), of Agrostemma githago L. (corn cockle) and of Asparagus officinalis L. (asparagus), and from the latex of Hura crepitans L. (sandbox tree)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06155.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53618227&oldid=1561113328"